Sauerer Tatjana, Lischer Christopher, Weich Adrian, Berking Carola, Vera Julio, Dörrie Jan
RNA-based Immunotherapy, Hautklinik, Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg, Deutsches Zentrum Immuntherapie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Systems Tumor Immunology, Hautklinik, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen European Metropolitan Area of Nuremberg, Deutsches Zentrum Immuntherapie, Erlangen, Germany.
Front Microbiol. 2021 Dec 22;12:785662. doi: 10.3389/fmicb.2021.785662. eCollection 2021.
Merkel cell carcinoma (MCC) is a rare and highly aggressive cancer, which is mainly caused by genomic integration of the Merkel cell polyomavirus and subsequent expression of a truncated form of its large T antigen. The resulting primary tumor is known to be immunogenic and under constant pressure to escape immune surveillance. Because interferon gamma (IFNγ), a key player of immune response, is secreted by many immune effector cells and has been shown to exert both anti-tumoral and pro-tumoral effects, we studied the transcriptomic response of MCC cells to IFNγ. In particular, immune modulatory effects that may help the tumor evade immune surveillance were of high interest to our investigation. The effect of IFNγ treatment on the transcriptomic program of three MCC cell lines (WaGa, MKL-1, and MKL-2) was analyzed using single-molecule sequencing the Oxford Nanopore platform. A significant differential expression of several genes was detected across all three cell lines. Subsequent pathway analysis and manual annotation showed a clear upregulation of genes involved in the immune escape of tumor due to IFNγ treatment. The analysis of selected genes on protein level underlined our sequencing results. These findings contribute to a better understanding of immune escape of MCC and may help in clinical treatment of MCC patients. Furthermore, we demonstrate that single-molecule sequencing can be used to assess characteristics of large eukaryotic transcriptomes and thus contribute to a broader access to sequencing data in the community due to its low cost of entry.
默克尔细胞癌(MCC)是一种罕见且侵袭性很强的癌症,主要由默克尔细胞多瘤病毒的基因组整合及其大T抗原截短形式的后续表达引起。已知由此产生的原发性肿瘤具有免疫原性,并且一直面临着逃避免疫监视的压力。由于免疫反应的关键参与者γ干扰素(IFNγ)由许多免疫效应细胞分泌,并且已显示出具有抗肿瘤和促肿瘤作用,我们研究了MCC细胞对IFNγ的转录组反应。特别是,可能有助于肿瘤逃避免疫监视的免疫调节作用是我们研究的重点。使用牛津纳米孔平台的单分子测序分析了IFNγ处理对三种MCC细胞系(WaGa、MKL-1和MKL-2)转录组程序的影响。在所有三种细胞系中均检测到几个基因的显著差异表达。随后的通路分析和手动注释显示,由于IFNγ处理,参与肿瘤免疫逃逸的基因明显上调。在蛋白质水平上对选定基因的分析证实了我们的测序结果。这些发现有助于更好地理解MCC的免疫逃逸,并可能有助于MCC患者的临床治疗。此外,我们证明单分子测序可用于评估大型真核转录组的特征,因此由于其较低的入门成本,有助于社区更广泛地获取测序数据。